Clinical Trial Update: Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing single versus dual antiplatelet therapy after left atrial appendage occlusion is being conducted across multiple centers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Left Atrial Appendage Occlusion Complications

Snippet

Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita | Conditions: Left Atrial Appendage Occlusion, Antiplatelet Therapy | Phase 3 | Status: UNKNOWN